Rights & Society
EMA: New Tools to Speed Medicine Development
The European Medicines Agency (EMA) has launched three new features within its PRIME scheme to accelerate the development of medicines that address unmet medical needs. These tools provide enhanced support and interaction for developers of promising medicines. The goal is to bring innovative treatments to patients in the EU more quickly. This development aims to foster innovation and improve access to essential medicines.
EMA boosts medicine development for unmet needs with new PRIME tools.